Uncategorized
54 Biggest Movers From Yesterday
Today, 11:59 PM
Gainers
Flanigan's Enterprises, Inc. (NYSE: BDL) shares surged 40.6% to close at $34.90 on Tuesday after the company reported results for the 13 weeks and the 26 weeks ended April 3, 2021.
Uncategorized
Mid-Afternoon Market Update: Dycom Industries Drops Following Q1 Results; The Joint Corp Shares Slide
Today, 11:59 PM
Toward the end of trading Tuesday, the Dow traded down 0.09% to 34,362.49 while the NASDAQ fell 0.04% to 13,655.88. The S&P also fell, dropping 0.14% to 4,191.36.
Uncategorized
The Daily Biotech Pulse: Pfizer In Vaccine Supply Talks With India, Provention In Focus Ahead Of Briefing Doc, NeuroRx To List Via SPAC Deal
Today, 11:59 PM
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 24)
Uncategorized
Benzinga Pro’s Top 5 Stocks To Watch For Monday, May 24, 2021: NVDA, CREX, PRVB, CLPS, ZIP
Today, 11:59 PM
Today's 5 Stock Ideas
NVIDIA (NVDA) - Will report Q1 earnings after market close on Wednesday. Analysts expect EPS of $3.27 on sales of $5.39 billion.
Creative Realities (CREX) - The second-most
Uncategorized
The Week Ahead In Biotech (May 23-29): Eton, Lantheus FDA Decisions, Adcom Test For Provention, Chiasma Data Presentation
Today, 11:59 PM
Biotech stocks advanced in the week ended May 21, as risk aversion forced traders to buy into defensives. As earnings news flow tapered, stocks took cues from clinical readouts.
Uncategorized
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
Today, 11:59 PM
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 11)
Uncategorized
Earnings Scheduled For May 6, 2021
Today, 11:59 PM
Companies Reporting Before The Bell
• ViacomCBS (NASDAQ:VIAC) is projected to report quarterly earnings at $1.22 per share on revenue of $7.30 billion.
Uncategorized
Attention Biotech Investors: Mark Your Calendar For May PDUFA Dates
Today, 11:59 PM
Following a mixed month in April, the Food and Drug Administration sets out to review another slate of drugs in May.